REVIEW ARTICLES

1. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis☆
2. Dysregulation of glutathione synthesis in liver disease☆
3. MiR-22 as a metabolic silencer and liver tumor suppressor☆
4. Intestinal barrier function and metabolic/liver diseases☆
5. Nuclear receptors and non-alcoholic fatty liver disease:An update☆

ORIGINAL ARTICLES

1. The metabolite,alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism☆
2. Efficacy and safety of direct-acting antiviral agent regimens in a realworld cohort of adult Chinese patients with chronic hepatitis C virus infection☆